case_images: PMC11182103_01
case_images: Case 1: effect of the treatment with platelet-rich plasma eye drops on non-healing persistent epithelial defects (PEDs). (A) right eye before treatment; (B) left eye before treatment; (C) right eye after 3 months of treatment; and (D) left eye after 3 months of treatment.
case_images: fopht-03-1215848-g001.jpg
case_images: PMC11182103_01_fopht-03-1215848-g001.jpg
case_images: f1
case_images: Figure 1 . Furthermore, 3 months after PRP eye drops treatment suspension, the clinical features remained stable without any further need for corticosteroid treatment.
case_images: PMC11182103_02
case_images: Case 2: effect of the treatment with platelet-rich plasma eye drops on non-healing persistent epithelial defects (PEDs) in a patient who previously underwent radial keratotomy. (A) right eye before treatment; (B) left eye before treatment; (C) right eye after 3 months of treatment; and (D) left eye after 3 months of treatment.
case_images: fopht-03-1215848-g002.jpg
case_images: PMC11182103_02_fopht-03-1215848-g002.jpg
case_images: f2
case_images: The results are shown in  Table 1  and  Figure 2 .
case_images: PMC11182103_03
case_images: Case 3: effect of the treatment with platelet-rich plasma eye drops on non-healing persistent epithelial defects (PEDs). (A) right eye before treatment; (B) left eye before treatment; (C) right eye after 3 months of treatment; and (D) left eye after 3 months of treatment.
case_images: fopht-03-1215848-g003.jpg
case_images: PMC11182103_03_fopht-03-1215848-g003.jpg
case_images: f3
case_images: The results are shown in  Table 1  and  Figure 3 .